4.7 Article

NF-κB and EGFR participate in S1PR3-mediated human renal cell carcinomas progression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial

Luc Bergougnan et al.

Summary: The study aimed to investigate the endothelial-protective properties of SAR247799, a G-protein-biased S1P(1) agonist, in type-2 diabetes patients. Results showed that SAR247799 was as effective as sildenafil in promoting endothelial effects in humans, with minimal impact on lymphocyte counts and heart rate. Further clinical testing of SAR247799 at doses <= 5 mg is warranted in vascular diseases associated with endothelial dysfunction.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Sphingosine-1-Phosphate Receptor 3 Potentiates Inflammatory Programs in Normal and Leukemia Stem Cells to Promote Differentiation

Stephanie Z. Xie et al.

Summary: The study reveals the important regulatory role of S1PR3 in AML patients, promoting myeloid differentiation and activating inflammatory programs, showing a continuous variation from primitive to mature myeloid states. This finding opens new avenues for specific therapeutic target identification in different AML subsets.

BLOOD CANCER DISCOVERY (2021)

Article Multidisciplinary Sciences

Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases

Brunilde Gril et al.

NATURE COMMUNICATIONS (2018)

Review Cell Biology

GPCRs: Emerging anti-cancer drug targets

Ainhoa Nieto Gutierrez et al.

CELLULAR SIGNALLING (2017)

Review Oncology

Treatment of renal cell carcinoma: Current status and future directions

Pedro C. Barata et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Oncology

Sphingosine-1 Phosphate: A New Modulator of immune Plasticity in the Tumor Microenvironment

Yamila I. Rodriguez et al.

FRONTIERS IN ONCOLOGY (2016)

Review Biochemistry & Molecular Biology

The complexity of NF-κB signaling in inflammation and cancer

Bastian Hoesel et al.

MOLECULAR CANCER (2013)

Article Biotechnology & Applied Microbiology

Trends in the exploitation of novel drug targets

Mathias Rask-Andersen et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Review Pharmacology & Pharmacy

The NF-kappa B activation pathways, emerging molecular targets for cancer prevention and therapy

Yong Lin et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2010)

Article Biochemistry & Molecular Biology

Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro

Viviana Anelli et al.

FASEB JOURNAL (2010)

Article Neurosciences

Sphingosine-1-Phosphate Elicits Receptor-Dependent Calcium Signaling in Retinal Amacrine Cells

Scott Crousillac et al.

JOURNAL OF NEUROPHYSIOLOGY (2009)

Review Oncology

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Jeffrey A. Engelman

NATURE REVIEWS CANCER (2009)

Review Physiology

Estrogen signaling through the transmembrane G protein-coupled receptor GrPR30

Eric R. Prossnitz et al.

ANNUAL REVIEW OF PHYSIOLOGY (2008)

Review Biochemistry & Molecular Biology

Calcium signaling

David E. Clapham

Review Cell Biology

Cell migration in tumors

H Yamaguchi et al.

CURRENT OPINION IN CELL BIOLOGY (2005)

Review Biochemistry & Molecular Biology

Cellular motility driven by assembly and disassembly of actin filaments

TD Pollard et al.